A multicentric study identifies a new biomarker for vascular dementias

(IDIBELL-Bellvitge Biomedical Research Institute) Lipocalin 2 strongly emerges as a possible new biomarker for vascular dementia. The increase of this protein in the cerebrospinal fluid has been validated in four groups of patients from four European countries, becoming a strong candidate for vascular dementia diagnosis. Moreover, the study indicates that lipocalin 2 discriminates vascular dementia from Alzheimer's with high precision, something very hard until now.